The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
-
Azanza Perea, José Ramón (Clínica Universidad de Navarra)
;
Grau, Santiago (Hospital del Mar (Barcelona, Catalunya)) ;
Vázquez, Lourdes (Hospital Clínico Universitario (Salamanca)) ;
Rebollo, Pablo (Ingress-health) ;
Peral, Carmen (Pfizer) ;
López-Ibáñez de Aldecoa, Alejandra (Pfizer) ;
López-Gómez, Vanessa (Pfizer) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
